Search Within

Andrew Joseph Plodkowski

  1. "2020"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (7)
Groups
  1. Body Imaging Service (16)
  2. Radiology, Department of (16)
  3. Department of Medicine (15)
  4. Solid Tumor Oncology Division (14)
  5. Thoracic Oncology (14)
  6. Weinberg Fellows (9)

More Groups

People
  1. Hira Rizvi (10)
  2. Matthew Hellmann (10)
  3. Charles Rudin (7)
  4. Adam Schoenfeld (5)
  5. Jennifer Sauter (5)
  6. Jia Luo (5)

More People

Years
  1. 2020 (16)
Publications
  1. Journal of Clinical Oncology (7)
  2. Clinical Cancer Research (2)
  3. Journal of Thoracic Oncology (2)
  4. Annals of Oncology (1)
  5. Annals of Thoracic Surgery (1)
  6. Cell (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. Elsevier Inc. (3)
  3. American Association for Cancer Research (2)
  4. Biomed Central Ltd (1)
  5. Cell Press (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effect of STK11 mutations on efficacy of PD-1 inhibition in non-small cell lung cancer (NSCLC) and dependence on KRAS mutation status
    Meeting Abstract

    Ricciuti, B.; Arbour, K. C.; Lin, J. J.; Vokes, N.; Hoojghan, A. V.; Li, Y. Y.; Cherniack, A. D.; Recondo, G.; Lamberti, G.; Venkatraman, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Acquired resistance to PD-1 blockade in NSCLC
    Meeting Abstract

    Schoenfeld, A. J.; Rizvi, H.; Memon, D.; Luo, J.; Preeshagul, I. R.; Sauter, J. L.; Plodkowski, A. J.; Vanderbilt, C.; Miller, M. L.; Hellmann, M. D.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II study of TAK228 in patients with advanced non-small cell lung cancer (NSCLC) harboring NFE2L2 and KEAP1 mutations
    Meeting Abstract

    Paik, P. K.; Ahn, L. S. H.; Plodkowski, A. J.; Fan, P. D.; Rudin, C. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Long-term responders to PD-1 blockade in patients with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Luo, J.; Bandlamudi, C.; Ricciuti, B.; Vokes, N.; Schoenfeld, A. J.; Egger, J. V.; Sauter, J. L.; Plodkowski, A. J.; Preeshagul, I. R.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Molecular subtypes and clinical outcomes to initial systemic treatment in patients with small cell lung cancer
    Meeting Abstract

    Lai, W. C. V.; Egger, J. V.; Rizvi, H.; Richards, A. L.; Beras, A.; Baine, M. K.; Hsieh, M. S.; Chang, J. C.; Rekhtman, N.; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small-cell lung cancer and a poor performance status
    Meeting Abstract

    Alessi, J. V. M.; Ricciuti, B.; Aguilar, E. J.; Hong, F.; Wei, Z.; Nishino, M.; Plodkowski, A. J.; Sawan, P.; Luo, J.; Rizvi, H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Noninvasive early identification of therapeutic benefit from immune checkpoint inhibition
    Journal Article

    Nabet, B. Y.; Esfahani, M. S.; Moding, E. J.; Hamilton, E. G.; Chabon, J. J.; Rizvi, H.; Steen, C. B.; Chaudhuri, A. A.; Liu, C. L.; Hui, A. B.; more...
    Cell (2020)

    Fulltext@MSK | Save
  • Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance status
    Journal Article

    Alessi, J. V.; Ricciuti, B.; Jiménez-Aguilar, E.; Hong, F.; Wei, Z.; Nishino, M.; Plodkowski, A. J.; Sawan, P.; Luo, J.; Rizvi, H.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC
    Journal Article

    Hellmann, M. D.; Nabet, B. Y.; Rizvi, H.; Chaudhuri, A. A.; Wells, D. K.; Dunphy, M. P. S.; Chabon, J. J.; Liu, C. L.; Hui, A. B.; Arbour, K. C.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save